CN Stock MarketDetailed Quotes

301075 Tibet Duo Rui Pharmaceutical

Watchlist
  • 16.02
  • -1.83-10.25%
Market Closed Apr 16 15:00 CST
1.28BMarket Cap73.82P/E (TTM)

About Tibet Duo Rui Pharmaceutical Company

The company registered with the Qamdo Department of Industry and Commerce on December 22, 2016 and settled in the Qamdo Economic Development Zone in Tibet. The company is mainly engaged in R&D, production and sales of chemical preparations and their APIs. Since its establishment, the company has focused on product pipeline layout in the perioperative period and emergency rescue, and has now gained a strong competitive advantage in the plasma substitute segment. It was listed on the Venture Market of the Shenzhen Stock Exchange on September 29, 2021, and currently has a share capital of 80 million yuan. The company is mainly engaged in R&D, production and sales of chemical preparations and their APIs. The company's core product is sodium acetate Ringer injection, which is the first domestic generic drug launched through independent research and development.

Company Profile

Short Name-A多瑞医药
Symbol-A301075
Company NameTibet Duo Rui Pharmaceutical Co., Ltd.
Listing DateSep 29, 2021
Issue Price27.27
Shares Offered20.00M share(s)
FoundedDec 22, 2016
Legal Representativeyong deng
CEOyong deng
Secretarybo ao
Accounting FirmTianjian Certified Public Accountants (Special General Partnership)
Securities Representativeying liu
Legal CounselBeijing Zhonglun (Wuhan) Law Firm
Employees40
Phone027-83868180
Office Address6th Floor, Building 4, Fanhai International SOHO City, Central Business District, Jianghan District, Wuhan
Zip Code430021
Registered AddressArea A, Changdu Economic and Technological Development Zone, Tibet Autonomous Region (Taiming Biotechnology)
Fax0895-4892099
Emailxizangduorui@duoruiyy.com
Business License540300200007405
BusinessLicense projects: pharmaceutical wholesale; Class III medical device management; food production; food sales; drug import and export; health food production; special medical formula production; pharmaceutical contract production; pesticide wholesale; veterinary drug management (projects subject to approval according to law, approval by relevant departments before business activities can be carried out) General projects: Class I medical device sales; Class II medical device sales; cosmetics wholesale; disinfectant sales (excluding hazardous chemicals); technical services, technology development, technical consultation, technical exchange, technology transfer, technology promotion; medical use of protective equipment for medical personnel; medical use Wholesale of masks; sales of specialty chemical products (excluding hazardous chemicals); sales of food additives; acquisition of Chinese herbal medicines; remote health management services; information consulting services (excluding licensed information consultation services); health consulting services (excluding medical services); health food (pre-packaged) sales; import and export of goods; technology import and export; chemical product sales (excluding licensed chemical products); sales of formula food for special medical purposes; marketing planning; feed additive sales; electronic product sales (the above business scope is approved by the registration authority). The company's business scope is ultimately subject to the business scope approved by the industrial and commercial registration authority.

Company Executives

  • Name
  • Position
  • Salary
  • yong deng
  • Chairman,directors,general manager
  • 680.40K
  • shaozhong zhang
  • Vice Chairman,directors
  • 630.40K
  • qin deng
  • directors
  • 114.30K
  • fen jin
  • directors,Deputy General Manager
  • 415.30K
  • yingfei liu
  • Independent directors
  • 80.00K
  • yunguo wang
  • Independent directors
  • 60.00K
  • fei qi
  • Independent directors
  • 80.00K
  • bo ao
  • Board Secretary,Deputy General Manager
  • 332.70K
  • ying liu
  • Securities affairs representative
  • --
  • hongwei zhao
  • Chairman of the Supervisory Board,auditors
  • 219.70K
  • jiali zhou
  • auditors
  • 112.30K
  • zeyu cai
  • Deputy General Manager
  • 505.30K
  • wengang wei
  • Deputy General Manager
  • 420.10K
  • zhichun huang
  • Deputy General Manager
  • 507.80K
  • chao li
  • Chief Financial Officer
  • 296.70K
  • pei si
  • Head of Internal Audit
  • --
  • tang wang
  • Employee supervisors
  • 262.10K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg